Obesity is a chronic inflammatory disease in which the physiological resolution of inflammation is attenuated, leading to low-grade inflammation throughout the body. However, the heat shock response, which is a key component of the physiological response to resolve inflammation, is seriously hampered in adipose tissue and other metabolic organs (e.g. skeletal muscle, liver, pancreatic b-cells) in metabolic diseases. In this review, we hypothesize that adipocyte metabolic stress triggers the onset of fat cell senescence, and companion senescence-associated secretory phenotype (SASP), and that such a scenario is responsible for attenuating the resolution of inflammation.
INTRODUCTION
Acute inflammation is a highly adaptive and protective response of multicellular organisms. Inflammation originated to limit invasion and attack by foreign agents, permitting tissue repair after the elimination of the invader/pathogen by the immune system. On the contrary, the incidence of chronic metabolic diseases, such as obesity, type 2 diabetes, cardiovascular diseases and certain types of cancer, is rising. The above diseases are linked by a chronic inflammatory status. This raises the question as to why does a 'normal' inflammatory response not resolve and result in the development of such diseases?
Considering human evolution, one can appreciate that human genetics and metabolism, at present, do not differ too much from that of 6-8 million years ago, when hominids developed separately from the chimpanzees or after the phylogenetic split between the Neanderthals and modern man about activity changed enormously during the past 10 000 years. Interestingly, short-term consumption of paleolithic, hunter-gatherer type diet improves blood pressure, glucose tolerance, insulin sensitivity and plasma lipid profile [4] . Therefore, today's human population is exposed to a high-energy content, as compared to our nomadic ancestors.
It is now clear that the mechanisms underlying chronic metabolic inflammatory diseases converge at a lifestyle involving 'high-energy intake-low physical exercise' with a genetic background favoring energy conservation. The modern way of life in many 'advanced' economies has worsened this scenario and, without lifestyle modification, many humans will ultimately become both obese and diabetic. In fact, it has been recently reported, in a 23-year follow-up study, that cardiovascular mortality, all-cause mortality and diabetes prevalence can be reduced in people submitted to a lifestyle intervention program [5] . But what is the link between the metabolically economic human organism and unresolved inflammation? Moreover, why and how does obesity hamper the resolution of inflammation?
In this study, we shall discuss the outcomes and potential mechanisms associated with chronic positive energy balance (particularly if accompanied by a diet rich in saturated fatty acids), chronic adipose inflammation and failure to bring about resolution of inflammation. Adipocytes may engage in cellular senescence, an alternative response to the unfolded protein response (UPR), avoiding apoptosis.
RESOLUTION OF INFLAMMATION
Rapid triggering of inflammation is an evolutionarily conserved response that is essential for whole organism protection against pathogens and for stimulation of repair to tissue injuries. Accordingly, acute inflammation is a quick and sometimes very aggressive reaction in which cells of innate immune system are recruited within minutes (neutrophils) to hours (monocytes/macrophages) to the site of injury/invasion. Unless the underlying inflammatory stimulus is removed within a short time frame (a few days), escalation of the immune response will occur. During the activation of an inflammatory response, production of proinflammatory arachidonic acid-derived prostaglandins as well as other lipid mediators and vasoactive compounds occurs, thus increasing vascular permeability and allowing the arrival and activation of inflammatory cells and tissue repair [6] .
It has been reported that maximal cyclooxygenase-2 (COX-2)-dependent prostaglandin E 2 (PGE 2 )
KEY POINTS
Physiological resolution of inflammation depends on the existence of an active and functional heat shock response, particularly because the major heat shock protein (HSP70) is a potent anti-inflammatory signal. The main HSF1 is also involved in terminating acute inflammatory responses. Failure in arming a healthy heat shock (HS) response leads to a chronic inflammatory situation.
During the establishment of obesity and visceral adiposity, there is a conspicuous and increasing activation of inflammatory pathways in metabolic organs, such as adipose tissue, skeletal muscle and liver. This is because risk factors (e.g. hyperglycemia, high-cholesterol and high-fat diet) for such diseases are inflammatory in nature and persistently present, so that all target tissues are affected, commencing with white adipose tissue.
In view of unresolved inflammation, enhanced NLRP3 inflammasome-mediated activation of caspase-1 takes place, leading to the cleavage of HuR, an mRNAbinding protein that enhances the expression of the antisenescence sirtuin SIRT1 in adipocytes. However, SIRT1 commands both transcription and activity of HSF1, so that chronic NLRP3 inflammasome activation blocks heat shock response. As a consequence, the expressions of HSP70 and HSF1 are markedly reduced in metabolic tissues, as obesity cannot be resolved.
The perpetuation of unresolved inflammation promotes a state of cellular senescence and the undesirable SASP in adipocytes. SASP, however, is highly proinflammatory and, spreading to remaining tissues, determines the impairment of HS response in those cells.
Fortunately, inducers of heat shock response, such as heat shock itself, physical exercise and calorie restriction, are capable of breaking the vicious cycle leading to the re-establishment of resolution of inflammation in target tissues. Moreover, these observations may have an important diagnostic value for severely obese, diabetic, cardiovascular disease and NAFLD patients, since 'HSP70 status' may be assessed from the ratio of extracellular (plasma) to intracellular (circulating blood mononuclear cells) HSP70 content in just a small blood drop sample. production occurs at 2 h, whereas COX-2 expression is much higher at 48 h, but proinflammatory PGE 2 production is much lower [7] . Additionally, and perhaps unexpectedly, both selective COX-2 inhibitors and dual COX-1/COX-2 blockers inhibit early phase but strongly exacerbate inflammation at mononuclear stage (48 h), thus preventing the resolution phase of inflammation [7] . Therefore, the so-called 'bad COX', responsible for the production of proinflammatory eicosanoids and cytokines, is not that 'bad' since it is crucial for the resolution of inflammation [8] .
During the overall inflammatory response (including its resolution phase), there is a finely orchestrated expression of inducible proteins centered at nuclear transcription factors from the kappa light chain enhancer of activated B cells (kB) family (NF-kB) [9] , which drive inflammation during the initial phase, but simultaneously arm its resolution. At the start of the inflammatory response and under the control of NF-kB, inducible enzymes (including COX-2) drive the synthesis of PGE 2 , which induces fever by upwardly changing the body temperature set point. Consequently, the highly evolutionarily conserved heat shock response initiates the activation of a transcriptional program based on the activation of heat shock transcription factor-1 (HSF1) [10] . The chief impact of HSF1 activation is the elevated production of the heat shock proteins (HSP) whose major representative is the 70-kDa family of HSP (HSP70). Small HSPs induced by fever, such as HSP27, also contribute to cytoprotection [11, 12] .
Heat stress will stimulate HSF1-induced HSP70 expression, thus protecting cells against proteotoxic stress so that the heat shock response supports proteostasis (protein homeostasis) and cytoprotection [13] . In addition to this, hyperthermia enhances Toll-like receptor-4 (TLR4) expression and downstream signaling in vivo [14] , whereas activation of TLR2, TLR3 and TLR4 acts synergistically with feverassociated hyperthermia to induce HSP70 expression and release to the extracellular space both in vivo and in vitro [15] .
Apart from being a molecular chaperone which is employed to reduce the formation of protein aggregates and reverse protein denaturation, HSP70 is able to associate with the complex formed by NF-kB with its inhibitor (IkB), thus impeding NF-kB translocation to the nucleus [16] . Therefore, the heat shock response is anti-inflammatory. Additionally, PGE 2 and other prostaglandins produced during the onset of inflammation may be converted into their respective electrophilic dehydration products, such as PGA 2 and J-family prostaglandins, which are a,b-unsaturated cyclopentenone prostaglandins (cyPGs) possessing strong anti-inflammatory activities in vitro as well as in vivo [17] . As demonstrated in classic studies by Professor M. Gabriella Santoro's group in Italy, this is partially dependent on cyPGs inhibition of NF-kB activation, but also because cyPGs are the strongest physiological inducers of HSP70 alongside heat shock itself. In other words, cyPG anti-inflammatory action is maximal only if HSP70 expression is elevated. Also, cyPGs are inflammation-derived anti-inflammatory compounds by virtue of directly inhibiting IkB kinase-b (IKKb), which phosphorylates IkB leading to NF-kB activation during inflammation [18] . Moreover, it has recently been shown that heat shock-activated HSF1 directly controls COX-2 transcription, thus allowing high throughput PGE 2 production during inflammation [19] . Figure 1 summarizes heat shock response during the resolution of inflammation.
HEAT SHOCK RESPONSE IN CHRONIC INFLAMMATORY DISEASES
The heat shock response is critical to promote the resolution of inflammation. Numerous studies, however, have indicated that heat shock response is severely impaired in metabolic tissues during chronic inflammation. With respect to insulin resistance and type 2 diabetes, it was found that the expression of mRNA coding for the inducible form of HSP70 (HSPA1A gene) was dramatically reduced (90% decrease) in skeletal muscle biopsies of type 2 diabetes patients as compared to healthy volunteers [20] . Similar observations have been reported in obese and nonobese type 2 diabetes patients, in which a marked reduction in the protein expression of HSP70 has been noticed in comparison with obese controls [21 & ]. Moreover, type 2 diabetes patients show decreased intramuscular expression of both HSP70 and heme-oxygenase [22] , so that heat shock response-associated antiinflammatory and antioxidant defenses are compromised leading to an inflammatory state, high nitric oxide synthase (NOS)-2-dependent nitric oxide production and impaired insulin receptor downstream signaling pathways function by S-nitrosation [23] . We (DiNaso et al., unpublished observations) also observed that HSF1-HSP70 axis is progressively suppressed in adipose tissue and liver of insulin resistant obese patients, as nonalcoholic fatty liver disease (NAFLD) evolves from steatosis, towards more inflammatory forms of the disease, for example, steatohepatitis accompanied by fibrosis. Suppression was found to be strongly correlated with the degree of enhancement of c-Jun N-terminal kinase (JNK)1 and JNK2 expression in adipose tissue, which was followed by similar rises in the amounts of Thr183/Tyr185-diphosphorylated, thus activated, p-JNK1 and p-JNK2 in the same tissue. Hence, adipose tissue of insulin resistant patients is associated with a suppressed heat shock response. This is a complex situation because stress-induced HSP70 inhibits JNK-dependent signal transduction [24] .
The association between NF-kB-centered unresolved inflammation and obesity has been recognized for a relatively long time and involves the UPR (a cellular reaction to overnutrition) and endoplasmic reticulum stress as observed in obesity, atherosclerosis, insulin resistance and type 2 diabetes [25] [26] [27] [28] . In all these cases, unremitted low-grade inflammation, which follows chronic endoplasmic reticulum stress, is a consequence of impaired resolution of inflammation [29] .
Interestingly, HSP70 exported to the extracellular space (eHSP70), where it functions as a stress signaling and proinflammatory molecule possibly by acting via TLR2 and TLR4 (see, for instance [15] ), has been reported to be negatively correlated with intramuscular HSP70 content [21 & ]. Indeed, elevated levels of eHSP70 are positively associated with insulin resistance in elderly volunteers and induce TLR-dependent b-cell failure [30] .
In total, low heat shock response pathway activity seems to be at the heart of insulin resistance and aggravation of type 2 diabetes. Enhanced HSP70 expression has been convincingly demonstrated to protect against obesity-induced insulin resistance in both humans and animal models of obesity [31] , whereas pharmacological (e.g. the hydroxylamine derivative BGP-15, now under clinical trial) as well as physiological (hyperthermic, hot tube) treatments have started to be considered as promising therapeutic approaches in type 2 diabetes [32 & ]. In fact, by using a mouse model of atherosclerosis, we heat-shocked the animals (41.58C for 15 min) once a week, over 8 weeks, observing an impressive remission of vascular disease, enhanced blood flow and attenuation of reduced expression of heat shock response proteins in the aortic arc (Bruxel et al., in preparation).
The interplay between obesity, diabetes, cardiovascular disease, chronic inflammation and HSP70 pathways encompasses a much more complex network operating at gene regulatory level. The promoter region of tumor necrosis factor (TNF)a gene contains an HSF1-binding site that represses TNFa transcription, and thus loss of this repressor results in sustained expression of TNFa [33] , which possibly explains why HSF1 knockout is associated with a chronic increase in TNFa levels and increased susceptibility to endotoxin challenge Heat shock response during acute inflammation and its resolution. During the establishment of an acute inflammatory process, a wide variety of signals lead to the activation of the nuclear factor NF-kB, the master regulator of inducible production of cytokines and inflammatory enzymes, such as cyclooxygenase-2 (COX-2). Arachidonic acid liberated in the cytosol after noxious stimuli is converted in inflammatory prostaglandins (PGs), among them PGE 2 , which induces hyperthermia. Fever, in turn, activates heat shock factor-1 (HSF1), leading to the expression of anti-inflammatory and cytoprotective 70-kDa heat shock proteins (HSP70) that turn NF-kB downstream pathways off. At the same time, fever-activated HSF1 induces the expression of more COX-2 molecules, which in turn exacerbate PGE 2 production. As the inflammation progresses over 24-48 h, PGE 2 and other prostanoids may be converted into cyclopentenone PGs (cyPGs), such as PGA 2 .
CyPGs are the strongest inducers of HSF1 activation along with heat shock, so that inflammation can be resolved within its own. Arrows indicate stimulation of the indicated pathways while broken lines represent inhibition. [24, 34] . Regulation of this network in the opposite direction has also been reported: TNFa may transiently repress HSF1 activation [35] . Furthermore, JNK1 was demonstrated to phosphorylate HSF1 in its regulatory domain causing suppression of HSF1-transcribing activity, whereas HSP70 prevents Bax activation by inhibiting the JNK/Bim pathway [34, 36] . Reduced HSP70 expression in obese patients was correlated with suppression of HSF1 protein expression [21 & ], an effect also observed in our atherosclerotic mouse model (Bruxel et al., in preparation) .
The information provided above lead to speculation regarding the mechanism of decreased HSF1 expression and reduced HSP70 availability in adipose tissue, skeletal muscle, liver and vascular cells. Obesity-induced cellular senescence of adipocytes may be a key component of this mechanism.
HEAT SHOCK RESPONSE AND HUR-SIRT1 DUET
As schematically shown in Fig. 2 , fat cell senescence and the associated senescence-associated secretory phenotype (SASP) may be an alternative mechanism to UPR in order for the cell to avoid apoptotic death, a result of an inoperative anti-inflammatory heat shock response. In fact, Tchkonia et al. [37] have recently hypothesized that a senescent-like state can emerge in fat cells from obese individuals (even young obese individuals), this being an adaptation to fat cell overutilization which resembles cellular aging. Also, high-fat diet (HFD)-induced obesity leads to vascular senescence in a process involving long-term activation of Akt1 (Ak mouse strain thymoma analogue type-1 ¼ protein kinase B) and mammalian target of rapamycin (mTOR) [38] . On the contrary, fibroblasts from adult segmental progerioid Werner syndrome, in which the cells undergo premature senescence, are associated with a strong positive feedback system in which overactivation of the p38-NF-kB pathway leads to SASP that then attenuates the expression of the mRNA-binding protein HuR (Human antigen R, a.k. as ELAV-1 for drosophila Embryonic Lethal, Abnormal Vision-like protein-1), a critical factor for activity of the nicotinamide adenine dinucleotide (NAD þ )-dependent protein deacetylase of class III family sirtuin-1 (SIRT1) [39,40 && ]. Tchkonia et al. Human antigen R (HuR) enhances the stability of numerous target mRNAs, including that encoding for SIRT1, via HuR association to the 3'-untranslated region of SIRT1 mRNA, which promotes its stability and thus a rise in SIRT1 protein expression levels [39] . The same authors have demonstrated that H 2 O 2 -induced oxidative stress disrupts HuR-SIRT1 mRNA interaction lowering cell survival in a cycle checkpoint kinase-2 (Chk2)-dependent manner [39] . In turn, SIRT1 enhances HSF1 expression [40 && ]. Moreover, activation of SIRT1 prolongs HSF1 binding to the promoters of heat shock genes by maintaining HSF1 in a deacetylated, DNA-binding competent state [42] , whereas heat shock itself increases cellular NAD þ /NADH ratio and augments the recruitment of SIRT1 to the HSP70 promoter [43] . SIRT1 knockdown, on the contrary, attenuates heat shock response [44] , whereas SIRT1 modulators were found to also modulate HSF1 activity and heat shock response in HeLa cell line [43] .
In addition to the above findings is the observation that SIRT1 attenuates saturated fatty acid-induced endoplasmic reticulum stress and insulin resistance in hepatocyte-like cells [45] . Also, reserveratrol, an inducer of SIRT1 metabolic action, is able to shift the metabolism of mammals on a high-calorie diet to that of animals maintained in a standard diet. Reserveratrol increases insulin sensitivity, 5'-AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-g (PPARg) coactivator-1a (PGC-1a), leading to increased mitochondrial number and oxidative metabolism [46] . Alongside other metabolic effects, SIRT1 activates PGC-1a by deacetylation [47] , whereas PGC-1a stimulates the production and secretion of a novel myokine (IRISIN) which acts in white adipose cells, both in vitro and in vivo, driving a brown-fat-like phenotype via stimulation of uncoupling protein-1 (UCP1) expression [48] . This links calorie restriction and physical exercise to protective energy-consuming oxidative metabolism. In parallel, a growing body of evidence highlights the very tight link between calorie-restriction/ exercise-induced heat shock response, through the participation of antisenescence SIRT1 pathways, and metabolic stress, in which chaperone induction during a healthy heat shock response is shown to be protective of metabolism, reducing the risk of metabolic syndrome and age-related diseases [49] . Hence HuR-SIRT1 interaction is of critical importance for the beneficial effects of anti-inflammatory and antisenescence heat shock response.
Following a cellular insult (e.g. genotoxic stress), HuR associates with SIRT1 mRNA, so triggering an antiapoptotic and prosurvival gene expression program [50] . However, HuR participation in cellular homeostasis goes beyond that, as HuR is involved in the differentiation of preadipocytes, including translation and stability of GLUT1 mRNA. Therefore, experimental data support a role for HuR in muscle and adipose tissue differentiation processes [51] . Contrarily, reduced HuR levels are associated with enhanced cellular senescence and because of these observations, HuR is considered a factor implicated in the maintenance of a 'young cell' [52] . Interestingly, heat shock and calorie restriction (which enhances SIRT1 deacetylase activity) seem to act synergistically with respect to the heat shock response [53] .
HEAT SHOCK RESPONSE AND INFLAMMASOME-MEDIATED SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE
The above considerations lead to the question as to why the HuR-SIRT1 axis is repressed during chronic inflammatory stimuli leading to SASP, thus maintaining the proinflammatory senescent phenotype. [54] . Caspases can mediate cleavage of HuR under different situations [55] . In parallel is the observation that HFD induces, in white adipose tissue, the cleavage of SIRT1 by caspase-1, which is, in turn, activated by the diet-induced inflammatory response in adipocytes [56 && ]. Moreover, high-fat feeding or systemic inflammation lead to the activation NLRP3 inflammasome, which is actually the key event that will lead to production and activation of caspase-1 [56 && ]. In 2008, a noncanonical mechanism of protein secretion, which is endoplasmic reticulum/Golgiindependent, was found to participate in the activation and export of several polypeptides, including proinflammatory cytokines IL-1b and IL-18, a process dependent on caspase-1 in inflammasomes. These observations implicated inflammatory stress-induced activation of caspase-1, cell survival and stimulation of regenerative processes [57] . Inflammasomes are large multimeric danger-sensing platforms that promote autocatalytic activation of caspase-1 and mediate the cleavage of inactive prointerleukins, among other proteins, into their active forms. Inflammasomes of NLR [nucleotidebinding oligomerization domain (NOD)-leucinerich repeat and pyrin-domain (LRP) containing protein] family are the best studied; particularly the NLRP3 inflammasome that mediates a series of metabolic diseases, including atherosclerosis and insulin resistance in adipocytes [58] . Remarkably, injuring stimuli that cause senescence, such as ultraviolet B (UVB) irradiation, also induce NLRP3 activation, whereas inflammasome activation seems to work as a 'danger sensor', as observed in the metabolic stress induced by high extracellular glucose that activates NLRP3 inflammasome [59] .
As discussed above, HFD triggers inflammationinduced cleavage of SIRT1-promoting metabolic stress in adipose tissue in a NLRP3 inflammasome fashion [56 && ], whereas genetic ablation of NLRP3-comprising components or caspase-1 in mice leads to improvement in glucose tolerance and insulin sensitivity in HFD animals [60] . This has been confirmed by others [61] . NLRP3 inflammasome senses obesity-associated danger signals thus leading to obesity-induced inflammation and insulin resistance [62] . Accordingly, hyperglycemia (and the consequent high intracellular glucose concentration), palmitate, uric acid and bacterial lipopolysaccharides (LPS) prime the activation of inflammasomes in target cells (adipocytes, macrophages, hepatocytes, islet of Langerhans cells and, possibly, many others), promoting the start of caspase-1 mRNA expression. Furthermore, islet amyloid polypeptide (IAPP), whose aggregates are toxic to b-cells and are associated with the pathogenesis of type 2 diabetes, are also able to activate the NLRP3 inflammasome [63] . Inflammasome activation can be stimulated by multiple signals, for example, glucose, palmitate, uric acid, ceramide, reactive oxygen species (ROS) and IAPP, in mononuclear cells of the immune system, including macrophages [64] .
Obesity supplies the first signals needed to prime NLRP3 inflammasome, which include modified low-density lipoprotein (LDL) particles and free fatty acids, particularly saturated [61] . This contributes to the modulation of adipocyte differentiation and insulin sensitivity during inflammasome-mediated caspase-1 activation [65] . Intracellular cholesterol crystals also activate the NLRP3 inflammasome in human macrophages [66] , whereas glucose is a direct stimulator of caspase-1 activity [64] . NLRP3 inflammasome activation is elevated in myeloid cells from type 2 diabetic patients, whereas treatment with the antidiabetic drug metformin, which enhances SIRT1 activity probably via AMPK, simultaneously blocks NLRP3 inflammasome activation [67] . Furthermore, reserveratrol inhibits an ionizing irradiation-induced inflammatory response by activating SIRT1 and attenuating NLRP3 inflammasome activation [68] .
HEAT SHOCK RESPONSE AND FAT CELL SENESCENCE
An important component of the 'heat shock response-senescence-resolution of inflammation' puzzle is related to the finding that in mouse macrophages, heat shock inhibits caspase-1 activity preventing inflammasome activation [69] . Indeed, other classical inducers of HSF1 activation, such as arsenical compounds, are able to inhibit the activation of NLRP1, NLRP3 and NLRC4 inflammasomes by preventing autoproteolytic activation of caspase-1 and the processing and secretion of IL-1b from macrophages [70] . The same finding was observed by treating myeloid cells from both mice (thioglycollate-activated peritoneal or bone marrow-derived macrophages) and humans (peripheral blood monocytes) with nitric oxide donors [such as the nitrosothiols S-Nitroso-N-acetyl-DL-penicillamine (SNAP) and S-Nitrosoglutathione (SNOG or GSNO)] [71] , which are known to induce HSF1 activation and heat shock response. Finally, heat shock treatment of atherosclerotic mice markedly induced SIRT1 expression paralleling a rise in HSF1 and HSP70 protein expression in the aortic arc (Bruxel et al., in preparation). Similar findings were obtained by Karpe and Tikoo [72 & ] who demonstrated that heat shock enhances angiotensin 1-7 signaling via the Mas/eNOS/SIRT1 pathway in HFD-fed, insulin-resistant rats and that inhibition of SIRT1 attenuates the favorable effects of heat treatment.
The diverted heat shock response pathway (Fig. 3) 
HS Response ?
↑ Glucose ↑ Fatty acids ↑ Insulin FIGURE 3. The fat cell senescence hypothesis of abrogated resolution of inflammation during chronic metabolic stress. A tentatively testable hypothesis of fat cell senescence as a triggering factor for the development of low-grade chronically inflammatory diseases is shown. Under normal nutrient supply (i.e. equivalent to energy expenditure, physical activity), glucose and fatty acids are utilized in adipose tissue upon physiological amounts of insulin. Any excess of demand is counteracted by enhanced HS response to avoid ER stress and the resulting UPR. When the supply of these fuels overcomes energy expenditure and high amounts of surplus energetic metabolites should be stored in adipose tissue under a higher insulin command, ER stress develops. Should energy expenditure be still and chronically lower than energy intake, ER stress is followed by the UPR, a cellular strategy evolved for the cells to evaluate the capacity to arrange a physiological HS response (which conveys cells to protein/metabolite homeostasis). If proteostasis is not attained but cells still have conditions to avoid apoptosis, an alternative metabolic pathway may be taken in which cells do not dye but activate senescence, assuming a senescenceassociated secretory phenotype (SASP). Under the persistence of risk factors, cells develop an UPR that is diverted to the inflammatory branch with continuous activation of NLRP3 inflammasome, thus activating caspase-1. This determines, in adipocytes, a SASP that can spread out to other cell types, including adipose tissue infiltrating macrophages, skeletal muscle cells, pancreatic b-cells, hepatocytes and vascular cells. SASP leads to cleavage of HuR which is responsible for enhancing SIRT1 expression. As a consequence, HSF1 expression and transcribing activity becomes depressed, because SIRT1 enhances both. Therefore, HS response is hindered accordingly thus blocking the resolution of inflammation. Moreover, senescent cells are resistant to undergo apoptosis (which should be an alternative to break this vicious cycle), so that chronically inflamed cells are likely to persist in tissues.
might be activated by heat treatment leading to enhanced SIRT1 expression, is now under investigation in our laboratories. However, following attenuation of NLRP3 inflammasome activation by heat shock treatment, Levin et al. [69] described that inhibition of caspase-1 activity after heat shock occurs independently of inflammasome platforms, via a titrable factor present in heat-shocked macrophages. Whether this titrable factor is the leucinerich repeat flightless-1 homolog (Fli-I)-interacting protein 2 (LRRFIP2), which has recently been shown to inhibit NLRP3 inflammasome activation in macrophages [73] , remains to be elucidated. In any case, heat shock treatment is capable of acting as a negative feedback for chronic inflammatory diseases, thus allowing the re-establishment of an anti-inflammatory heat shock response, thus reverting cellular senescence. Corroborating the above is the recent finding that hepatocyte senescence predicts NAFLD progression in humans [74] , whereas hepatocyte senescence is a general marker of human liver cirrhosis [75] , which is the next step of NAFLD progression. These observations are important because the application of physiologic inducers of the heat shock response (e.g. physical exercise and the heat shock treatment itself) may be a valuable and lowcost strategy to interrupt SASP that tends to spread from white adipose tissue to the rest of the body (Zhu et al., pp. 324-328). Enhanced consumption of resveratrol-containing food or even a 35-40%-calorie restriction may also be useful by potentiating heat shock response at the SIRT1 step (Fig. 3) . As a whole, these observations support the view that an improved heat shock response is a powerful tool for breaking the vicious cycle of metabolic-based chronic inflammatory diseases.
CONCLUSION
Taken as a whole, the above supports the notion that, in chronic metabolic inflammatory diseases, inflammation is firstly established in adipocytes challenged by excess saturated fatty acids, cholesterol, HFD and hyperglycemia. Such a persistent stimulus induces an UPR that is diverted to an inflammatory pathway because continuous inflammatory stimuli activate the NLRP3 inflammasome, leading to the activation of caspase-1 (Fig. 3) . Activated caspase-1, in adipocytes, results in a state of frank cellular senescence which culminates in SASP that can spread out to other tissues and cell types, including adipose tissue infiltrating macrophages, skeletal muscle cells, pancreatic b-cells, hepatocytes and vascular cells. In all these cell types, including adipocytes, SASP leads to cleavage of HuR, an mRNA-binding protein responsible for enhancing SIRT1 expression. As a consequence, HSF1 expression and transcribing activity becomes depressed, because SIRT1 enhances both. Therefore, the heat shock response is hindered accordingly and a state of enhanced inflammation is the result. Resolution of inflammation is impaired, thus impeding autophagy and an efficient resolution of UPR via the heat shock response. In addition, several studies indicate that senescent cells are resistant to apoptosis (which should be an alternative to break this vicious cycle), so that chronically inflamed cells are likely to persist in tissues [76] . Because of this, targeting senescent cells or SASP is expected to delay or even prevent a number of age-related chronic diseases [41 & ].
In conclusion, obesity-induced insulin resistance and comorbidities, type 2 diabetes, cardiovascular diseases, NAFLD are fat cell senescencebased inflammatory processes that may be suppressed by heat shock response inducers (e.g. mild heat shock, physical exercise and calorie restriction). This may also suggest that the perceived Gordian knot (an intractable problem that may be solved by 'thinking outside the box') of obesity-centered metabolic diseases may be about to be untied. Disseminating heat shock treatment and the heat shock response resulting in health benefits to obese, diabetic and cardiovascular patients is the next step.
'Quae medicamenta non sanat, ae ferrum sanat. Quae ferrum non sanat, ae ignis sanat. Quae vero ignis non sanat, ae insanabilia existimare oportet.' 'That which drugs fail to cure, the scalpel can cure. That which the scalpel fails to cure, heat can cure. If heat cannot cure, it must be determined to be incurable.' 
